Manulife Financial (MFC.TO) Buy, Sell or Hold

Home

Daily Stock Opinions and Ratings

Manulife Financial (MFC.TO)

57.19

+0.15 (0.26%)

as of Jun 26, 2026, 8:00:00 pm Market Open.

1634 watching

Investor Insights

Jun 27, 2026, 12:00 am

This summary was created by AI, based on 28 opinions in the last 12 months.

Manulife Financial (MFC) has received mixed reviews from experts, highlighting its strengths in capital management, particularly in Asia and wealth management. Several analysts view it as a reliable income stock, benefiting from a decent dividend yield, yet caution against its growth potential compared to Canadian banks. The company has faced short-term challenges, including mixed results from its alternative portfolio and limited growth in its U.S. operations, which has sparked some concerns. Analysts suggest waiting for opportunities to buy during pullbacks, given its valuation relative to major financials, alongside the potential for increased profitability stemming from rising interest rates. Overall, while MFC is generally recognized for its stability and improvements in earnings quality, it struggles to capture investor attention amidst recent market shifts.

Consensus

Hold

Valuation

Fair Value

Similar

SLF-T

TOP PICK

Over the last couple of years they made significant strides in hedging out a lot of their risk. We are now in a much better environment for insurance companies.

SELL

Significant dividend but this is a company that has a cloud over it again. When clients bring it in from outside, he tends to eliminate it. He not sure about their equity oriented investment insurance type plans. On a market, which he expects will be indifferent over the next 3 or 4 months, this stock won’t do very well. Their most recent earnings report was a disappointment. Also the Japan situation might come back and bite them.

COMMENT

You can write calls to lower your risk.

HOLD

Stock has not down well. Just as you think they are heading for a breakout, another issue sideswipes them. Will have to take a write down on their insurance policies in Japan, which was the fastest growing part of their business. Higher interest rates are good for their business and the stock market has improved. Think it has a lot more intrinsic value than the current price. You have to be patient.

TOP PICK

Thinks it could move back up to possibly the $20 level. $16 is the exit price.

DON'T BUY

Not positive on this one. Sold his holdings when he discovered it was really a leverage on the US stock market and US bond market interest rates. Would rather buy a life insurance company for their business, not their exposure to interest rates or the stock market.

PAST TOP PICK

(A Top Pick Apr 1/10. Down 11.26%.) Deploying its capital properly.

PAST TOP PICK

(Top Pick Apr 19/10, Down 10.42%) There is a bit of headwind at $19. Weak today because of a story in the paper today. This stock deserves a higher multiple. In 18-24 months they should be in good enough shape to raise the dividend again.

PAST TOP PICK

(A Top Pick Aug 19/10. Up 20.71%.) Technically it should go higher. Likes the sector.

BUY

Within a year you could see this stock north of $10. Solidified balance sheet, have all the capital they need. They have more credibility here. Delivered better numbers the last two quarters. Good international diversification. It’s the high-risk play in the financials.

BUY

$24 model price. He still recommends it. Add on any dips.

PAST TOP PICK

(Top Pick Mar 16/10, Down 13.90%) Still likes it. Thinks as interest rates and bond yields go up, they will make much more from assets under management. Doesn’t think their interests in Japan are material to their results. Investors are unduly negative on the stock.

DON'T BUY

Stock has been struggling for the last little while. Resistance at current levels. Out of the period of seasonal strength. Between Oct and Jan is it’s strong time. Different than banks, which are Feb to May. Stay away for now.

WEAK BUY

Their exposure to Japan shouldn’t be much. In the short term, he prefers banks over life companies.

PAST TOP PICK

(Top Pick Apr. 19/10, Down 7.21%) Well-known story, has recovered somewhat, but pulled back very recently. Unhedged to the market and had a billion and a half of product that they had to guarantee. In 12 to 18 months you might see a dividend increase. They have covered the hedge to more than half of where it was.

Showing 1,321 to 1,335 of 2,281 entries

Most Recent Experts

Jenny Harrington, CEO, Gilman Hill Asset Management

Gilman Hill Asset Management

Stephen Weiss, Founder, Short Hills Capital Partners

Short Hills Capital Partners

Kevin Simpson

Capital Wealth Planning

Bryn Talkington

Requisite Capital Management

Andrey Omelchak

LionGuard Capital Management

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at : [email protected].

Manulife Financial (MFC.TO)